IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0165183.html
   My bibliography  Save this article

Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study

Author

Listed:
  • Caijun Yang
  • Lina Wu
  • Wenfang Cai
  • Wenwen Zhu
  • Qian Shen
  • Zongjie Li
  • Yu Fang

Abstract

Objective: Drug shortages were a complex global problem. The aim of this study was to analyze, characterize, and assess the drug shortages, and identify possible solutions in Shaanxi Province, western China. Methods: A qualitative methodological approach was conducted during May–June 2015 and December 2015–January 2016. Semi-structured interviews were performed to gather information from representatives of hospital pharmacists, wholesalers, pharmaceutical producers, and local health authorities. Results: Thirty participants took part in the study. Eight traditional Chinese medicines and 87 types of biologicals and chemicals were reported to be in short supply. Most were essential medicines. Five main determinants of drug shortages were detected: too low prices, too low market demands, Good Manufacturing Practice (GMP) issues, materials issues, and approval issues for imported drugs. Five different solutions were proposed by the participants: 1) let the market decide the drug price; 2) establish an information platform; 3) establish a reserve system; 4) enhance the communication among the three parties in the supply chain; and 5) improve hospital inventory management. Conclusions: Western China was currently experiencing a serious drug shortage. Numerous reasons for the shortage were identified. Most drug shortages in China were currently because of “too low prices.” To solve this problem, all of the stakeholders, especially the government, needed to participate in managing the drug shortages.

Suggested Citation

  • Caijun Yang & Lina Wu & Wenfang Cai & Wenwen Zhu & Qian Shen & Zongjie Li & Yu Fang, 2016. "Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study," PLOS ONE, Public Library of Science, vol. 11(10), pages 1-16, October.
    • Handle: RePEc:plo:pone00:0165183
    DOI: 10.1371/journal.pone.0165183
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165183
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0165183&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0165183?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Petronille Bogaert & Tomasz Bochenek & Anna Prokop & Andrzej Pilc, 2015. "A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union’s Perspectives," PLOS ONE, Public Library of Science, vol. 10(5), pages 1-20, May.
    2. Pieter Dylst & Arnold Vulto & Brian Godman & Steven Simoens, 2013. "Generic Medicines: Solutions for a Sustainable Drug Market?," Applied Health Economics and Health Policy, Springer, vol. 11(5), pages 437-443, October.
    3. Kim Pauwels & Steven Simoens & Minne Casteels & Isabelle Huys, 2015. "Insights into European Drug Shortages: A Survey of Hospital Pharmacists," PLOS ONE, Public Library of Science, vol. 10(3), pages 1-13, March.
    4. Declan Butler, 2013. "Iran hit by drug shortage," Nature, Nature, vol. 504(7478), pages 15-16, December.
    5. Schweitzer, S.O., 2013. "How the US Food and Drug Administration can solve the prescription drug shortage problem," American Journal of Public Health, American Public Health Association, vol. 103(5), pages 10-14.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Xiaojie Yang & Li Liu & Yi Zheng & Xue Yang & Shanlin Sun, 2022. "Pricing Problems in the Pharmaceutical Supply Chain with Mixed Channel: A Power Perspective," Sustainability, MDPI, vol. 14(12), pages 1-20, June.
    2. Sundus Shukar & Fatima Zahoor & Sumaira Omer & Sundas Ejaz Awan & Caijun Yang & Yu Fang, 2022. "Experience of Pharmacists with Anti-Cancer Medicine Shortages in Pakistan: Results of a Qualitative Study," IJERPH, MDPI, vol. 19(23), pages 1-12, December.
    3. Jun Li & Di (Andrew) Wu, 2022. "The Price Effect of Drug Price Ceilings: Intended and Unintended Consequences," Management Science, INFORMS, vol. 68(8), pages 5758-5777, August.
    4. Asaeli Raikabakaba & Masoud Mohammadnezhad & Ledua Tamani & Devina Gaundan, 2022. "Drug Shortages and Its Effects on Service Delivery among Key Informants (KIs) in Fiji," Global Journal of Health Science, Canadian Center of Science and Education, vol. 14(5), pages 1-1, May.
    5. Caijun Yang & Wenfang Cai & Zongjie Li & Amy Theresa Page & Yu Fang, 2018. "The current status and effects of emergency drug shortages in China: Perceptions of emergency department physicians," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-14, October.
    6. Said, André & Goebel, Ralf & Ganso, Matthias & Zagermann-Muncke, Petra & Schulz, Martin, 2018. "Drug shortages may compromise patient safety: Results of a survey of the reference pharmacies of the Drug Commission of German Pharmacists," Health Policy, Elsevier, vol. 122(12), pages 1302-1309.
    7. András Fittler & Róbert György Vida & Valter Rádics & Lajos Botz, 2018. "A challenge for healthcare but just another opportunity for illegitimate online sellers: Dubious market of shortage oncology drugs," PLOS ONE, Public Library of Science, vol. 13(8), pages 1-17, August.
    8. Chen, Xu & Yang, Huan & Wang, Xiaojun, 2019. "Effects of price cap regulation on the pharmaceutical supply chain," Journal of Business Research, Elsevier, vol. 97(C), pages 281-290.
    9. Yulei Zhu & Yuqin Ren & Hui Wang & Wenqing Fang & Xinglu Xu & Ying Wang & Huizhen Dai & Xin Li, 2022. "The impact of policy on availability and price of low‐price medicines in public healthcare institutions: A retrospective survey in Nanjing, China," International Journal of Health Planning and Management, Wiley Blackwell, vol. 37(2), pages 1118-1130, March.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Josephine Walker & Betty B Chaar & Numa Vera & Alvish S Pillai & Jessy S Lim & Lisa Bero & Rebekah J Moles, 2017. "Medicine shortages in Fiji: A qualitative exploration of stakeholders’ views," PLOS ONE, Public Library of Science, vol. 12(6), pages 1-16, June.
    2. András Fittler & Róbert György Vida & Valter Rádics & Lajos Botz, 2018. "A challenge for healthcare but just another opportunity for illegitimate online sellers: Dubious market of shortage oncology drugs," PLOS ONE, Public Library of Science, vol. 13(8), pages 1-17, August.
    3. Kaveh Madani, 2021. "Have International Sanctions Impacted Iran’s Environment?," World, MDPI, vol. 2(2), pages 1-22, April.
    4. Vogler, Sabine & Fischer, Stefan, 2020. "How to address medicines shortages: Findings from a cross-sectional study of 24 countries," Health Policy, Elsevier, vol. 124(12), pages 1287-1296.
    5. Said, André & Goebel, Ralf & Ganso, Matthias & Zagermann-Muncke, Petra & Schulz, Martin, 2018. "Drug shortages may compromise patient safety: Results of a survey of the reference pharmacies of the Drug Commission of German Pharmacists," Health Policy, Elsevier, vol. 122(12), pages 1302-1309.
    6. Mondelo-García, Cristina & Mendoza, Elvia & Movilla-Fernández, María-Jesús & Coronado, Carmen, 2018. "Perceptions of pharmacists and physicians on generic substitution in a financial crisis context in Northwestern Spain: A qualitative study," Health Policy, Elsevier, vol. 122(12), pages 1316-1325.
    7. Elfi De Weerdt & Thomas De Rijdt & Steven Simoens & Minne Casteels & Isabelle Huys, 2017. "Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: An exploratory study," PLOS ONE, Public Library of Science, vol. 12(3), pages 1-15, March.
    8. Zaprutko, Tomasz & Kopciuch, Dorota & Bronisz, Maria & Michalak, Michał & Kus, Krzysztof & Nowakowska, Elżbieta, 2020. "Drug shortages as a result of parallel export in Poland – Pharmacists’ opinions," Health Policy, Elsevier, vol. 124(5), pages 563-567.
    9. Vogler, Sabine, 2024. "Tackling medicine shortages during and after the COVID-19 pandemic: Compilation of governmental policy measures and developments in 38 countries," Health Policy, Elsevier, vol. 143(C).
    10. Rozhin Doroudi & Pedro Sequeira & Stacy Marsella & Ozlem Ergun & Rana Azghandi & David Kaeli & Yifan Sun & Jacqueline Griffin, 2020. "Effects of trust-based decision making in disrupted supply chains," PLOS ONE, Public Library of Science, vol. 15(2), pages 1-21, February.
    11. Bocquet, François & Degrassat-Théas, Albane & Peigné, Jérôme & Paubel, Pascal, 2017. "The new regulatory tools of the 2016 Health Law to fight drug shortages in France," Health Policy, Elsevier, vol. 121(5), pages 471-476.
    12. Rabie Mahssouni & Mohamed Noureddine Touijer & Mohamed Makhroute, 2022. "Employee Compensation, Training and Financial Performance during the COVID-19 Pandemic," JRFM, MDPI, vol. 15(12), pages 1-19, November.
    13. Jonathan Minh Phuong & Jonathan Penm & Betty Chaar & Lachlan Daniel Oldfield & Rebekah Moles, 2019. "The impacts of medication shortages on patient outcomes: A scoping review," PLOS ONE, Public Library of Science, vol. 14(5), pages 1-17, May.
    14. Ulrik Hesse & Brian Godman & Max Petzold & Andrew Martin & Rickard Malmström, 2013. "Impact of Delisting ARBs, Apart from Losartan, on ARB Utilisation Patterns in Denmark: Implications for Other Countries," Applied Health Economics and Health Policy, Springer, vol. 11(6), pages 677-685, December.
    15. Kanavos, Panos, 2014. "Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States," Health Policy, Elsevier, vol. 118(2), pages 229-241.
    16. Kati Heiskanen & Riitta Ahonen & Risto Kanerva & Pekka Karttunen & Johanna Timonen, 2017. "The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland," PLOS ONE, Public Library of Science, vol. 12(6), pages 1-14, June.
    17. Emily Chen & Susan Goold & Sam Harrison & Iman Ali & Ibtihal Makki & Stanley S Kent & Andrew G Shuman, 2021. "Drug shortage management: A qualitative assessment of a collaborative approach," PLOS ONE, Public Library of Science, vol. 16(4), pages 1-13, April.
    18. Sundus Shukar & Fatima Zahoor & Sumaira Omer & Sundas Ejaz Awan & Caijun Yang & Yu Fang, 2022. "Experience of Pharmacists with Anti-Cancer Medicine Shortages in Pakistan: Results of a Qualitative Study," IJERPH, MDPI, vol. 19(23), pages 1-12, December.
    19. Tinne Gils & Claire Bossard & Kristien Verdonck & Philip Owiti & Ilse Casteels & Maria Mashako & Gilles Van Cutsem & Tom Ellman, 2018. "Stockouts of HIV commodities in public health facilities in Kinshasa: Barriers to end HIV," PLOS ONE, Public Library of Science, vol. 13(1), pages 1-12, January.
    20. Ezgi Demir & Peter M. Bican, 2023. "Patents and Sustainable Medical Treatment in Developing Countries: Lessons from COVID-19 Vaccines," Sustainability, MDPI, vol. 15(4), pages 1-19, February.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0165183. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.